Company Overview
Omega Healthcare Investors, Inc. operates as a Real Estate Investment Trust (REIT) that provides financing and capital to the long-term healthcare industry within the United States and the United Kingdom. The company specifically focuses its operations on skilled nursing and assisted living facilities, including care homes located in the United Kingdom, thereby serving a critical segment of the healthcare infrastructure. This entity functions within the Real Estate sector and the specialized industry of REIT - Healthcare Facilities, which implies a business model reliant on owning, operating, or financing income-producing healthcare properties. The company currently manages a market capitalization of $13.53B and generates annual revenue of $1.19B while employing 69 individuals. These valuation and revenue figures indicate that the company holds a significant position within its niche, commanding a substantial market value relative to its specific focus on healthcare real estate assets across two nations.
Financial Health
The company reports revenue of $1.19B over the trailing twelve months, with net income reaching $572.03M and EBITDA totaling $1.07B. The substantial gap between revenue and net income reveals a highly efficient cost structure typical of the REIT model, where the majority of revenue flows directly to the bottom line after minimal operating expenses. The company demonstrates strong financial flexibility with free cash flow of $759.89M, a figure that provides ample liquidity for debt servicing, capital expenditures, and potential special distributions without requiring external financing. Profitability is evidenced by three distinct margins: a gross margin of 98.6%, an operating margin of 63.2%, and a profit margin of 49.6%. The high gross margin indicates that the cost of revenue is negligible, while the operating and profit margins reflect significant operational efficiency and pricing power within the skilled nursing and assisted living sectors. On the balance sheet, the company holds $27.02M in cash against $4.30B in total debt, resulting in a debt-to-equity ratio of 79.02, which characterizes a highly leveraged financial structure common for REITs to maximize returns on equity. Short-term liquidity is assessed via a current ratio of 1.10, suggesting the company can meet its short-term obligations with slightly more current assets than liabilities. Regarding return metrics, the Return on Equity stands at 12.0% and the Return on Assets is 4.7%, revealing that management is effective at generating returns for shareholders relative to the equity invested, though asset-level returns are moderated by the high leverage profile.
Valuation Assessment
Valuation metrics indicate a trailing P/E ratio of 22.96 and a forward P/E of 20.74. The difference between these two figures implies that the market expects earnings growth in the future, as the forward multiple is lower, suggesting the stock is priced to grow or that analysts anticipate higher earnings per share in the coming year. The price-to-book ratio is 2.54, which indicates a market premium over the company's book value, reflecting the value investors place on the underlying healthcare real estate assets and the stability of the operating cash flows. Alternative valuation metrics further contextualize the stock's price, with a price-to-sales ratio of 11.37 and an EV/EBITDA of 16.55. These ratios suggest that the company trades at a premium relative to its sales and earnings before interest, taxes, depreciation, and amortization, consistent with high-quality REITs in the healthcare sector. Price volatility and trading range are defined by a 52-week high of $49.14 and a 52-week low of $35.04. Based on the provided data points, the current trading price sits within this historical range, bounded by the recent highs and lows observed over the past year. The beta value is 0.55, which means the stock exhibits lower price volatility relative to the broader market, moving with less intensity than the overall stock index during periods of market fluctuation.
Growth & Income
Growth dynamics are highlighted by a revenue growth rate of 14.3% and an earnings growth rate of 34.6% year-over-year. Earnings are growing significantly faster than revenue, which implies an improvement in operational leverage, margin expansion, or a shift in the mix of facilities that enhances profitability per unit of revenue. For dividend payers, the company offers a dividend yield of 6.0% with a payout ratio of 138.1%. This high payout ratio indicates that the company is distributing a portion of its earnings alongside other capital sources, such as cash reserves or debt proceeds, to maintain the yield level, which warrants close monitoring of the sustainability given the earnings growth rate. The overall growth and income profile presents a scenario of strong earnings expansion supported by a high-yield dividend, though the payout ratio suggests the distribution policy is aggressive relative to current net income alone.